benzo[a]pyrene
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 17, 2018 (NCT03318978)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03631667 | Early Phase 1 (Phase 1) | Nov 1, 2019 | Lawrence Livermore National Laboratory, National Institute of Environmental Health Sciences (NIEHS), Oregon State University |
| NCT03802721 | Early Phase 1 (Phase 1) | Jan 1, 2019 | Lawrence Livermore National Laboratory, National Institute of Environmental Health Sciences (NIEHS), Oregon State University |
| NCT03318978 | Early Phase 1 (Phase 1) | Apr 17, 2018 | Lawrence Livermore National Laboratory, National Institute of Environmental Health Sciences (NIEHS), Oregon State University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lawrence Livermore National Laboratory | Government | 3 | 0 | 1 | 2018 |
| National Institute of Environmental Health Sciences (NIEHS) | Government | 3 | 0 | 1 | 2018 |
| Oregon State University | Academic/Hospital | 3 | 3 | 1 | 2018 |
3 organizations
Page 1 / 1